Business
Student
Gaming
- Shop Shop All Gaming Gaming Laptops Gaming Desktops Gaming Accessories
  Gaming By Brand
  Lenovo Legion Lenovo LOQ
- Best Sellers Legion Pro 5i 16" Legion Tower 7i Legion Go
  Quick Links
  Legion Gaming Community Legion Ultimate Support

Buy More, Save More! Earn EXTRA stackable savings when spending $500 or more with code LENOVOWKND. Shop Now >
Shopping for a business? New Lenovo Pro members get $100 off first order of $1,000+, exclusive savings & 1:1 tech support. Learn More >
Need it today? Buy online, pick up select products at Best Buy. Shop Pick Up >
My Lenovo Rewards! Earn 3%-9% in rewards and get free expedited delivery on select products. Join For Free >
Business Financing Limited Time Offer! Get 0% interest for 90 days, select Lenovo Financing at checkout. Learn More

QR Pharmaceuticals

Building a reputation as a global research center.

How QR Pharmaceuticals races toward new drug discoveries and greater efficiency with integrated, data-driven operations on hyperconverged infrastructure from Nutanix and Lenovo.

“By embracing a hyperconverged infrastructure from Lenovo and Nutanix, we’ve demolished the barriers to digital transformation. Looking ahead, we plan to use the platform to build next-generation big-data analytics technologies—empowering QR Pharmaceuticals to develop innovative treatments that benefit the whole world."

Gao Yang,

Director of Information Department, QR Pharmaceuticals

At-a-Glance

Customer: QR Pharmaceuticals
Industry: Healthcare
Product Family: lenovo:product-group-and-series/L110056/L210089
Region: China
Processor: Intel
Topic: Hyperconverged Infrastructure

Building a reputation as a global research center

Wuhan Qirui Pharmaceutical Co., Ltd. (hereafter referred to as QR Pharmaceuticals) is based at the Miaoshan Medical Park, Donghu Development Zone in Wuhan, China, and is part of the Wuhan Qirui Technology Development Co., Ltd. Group.

QR Pharmaceuticals has led innovative research projects on cerebrovascular, digestive, and respiratory diseases, and fungal infections in accordance with international standards. The company has undertaken research as part of the National Key New Drug Creation Program—a drug development program sponsored by China’s Ministry of Science and Technology. QR Pharmaceuticals has also conducted more than 40 research projects for the National Development and Reform Commission and the Ministry of Industry and Information Technology.